Breaking: Robust Growth in Cancer Biomarker Market Ahead
The Cancer Biomarker Market is witnessing significant momentum, highlighted by a projected increase from USD 17.42 billion in 2024 to approximately USD 33.28 billion by 2035. This represents a compound annual growth rate (CAGR) of 6.06%. Driving this acceleration are advancements in technology and a heightened focus on personalized medicine, which continues to reshape diagnostics and treatment...
0 Comments 0 Shares 69 Views 0 Reviews